Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.31

MYGN FY 2006 Earnings — Myriad Genetics, Inc. Revenue & Financial Results | Market Cap Arena

MYGNMyriad Genetics, Inc.

$460M

FY 2006 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$157M

Gross Profit

$126M80.4% margin

Operating Income

-$48M-30.4% margin

Net Income

-$35M-22.3% margin

EPS (Diluted)

$-0.43

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$37M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$372M

Total Liabilities

$32M

Stockholders' Equity

$340M

Cash & Equivalents

$143M

← FY 2007 All Quarters